SCHEMBL5258790

SCHEMBL5258790

O=C(NCCN1CCOCC1)c1cc(Cl)ccc1NC(=O)c1cccc2ccccc12

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.70
ALDH1A1 P00352 3/20 0.63
KMT2A Q03164 3/20 0.63
CYP2C19 P33261 2/20 0.63
MEN1 O00255 2/20 0.63
CYP1A2 P05177 1/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2D6 P10635 1/20 0.63
CYP2C9 P11712 1/20 0.63
CNR1 P21554 1/20 0.59
CNR2 P34972 1/20 0.59
BCL3 P20749 6/20 0.59
LMNA P02545 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
RAB9A P51151 1/20 0.53
GAA P10253 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5261323 0.94 HTT (0.62) HTTALDH1A1KMT2ACYP2C19MEN1
SCHEMBL17554166 0.89 BCL3 (0.73) HTTALDH1A1KMT2AMEN1BCL3
SCHEMBL4191608 0.89 CNR1 (0.59) HTTALDH1A1KMT2ACYP2C19MEN1
SCHEMBL4204512 0.87 HTT (0.55) HTTALDH1A1KMT2ACYP2C19MEN1
SCHEMBL5795351 0.86 KMT2A (0.63) HTTALDH1A1KMT2ACYP2C19MEN1
SCHEMBL31518356 0.86 KMT2A (0.63) HTTALDH1A1KMT2ACYP2C19MEN1
SCHEMBL17554125 0.83 BCL3 (0.74) HTTALDH1A1KMT2ABCL3LMNA
SCHEMBL4195045 0.83 MEN1 (0.57) HTTALDH1A1KMT2AMEN1CNR1
SCHEMBL5258216 0.83 CNR1 (0.67) HTTALDH1A1KMT2ACYP2C19MEN1
SCHEMBL4190787 0.82 CNR1 (0.65) HTTALDH1A1KMT2ACYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756044-A1 THERAPEUTIC COMPOUNDS AstraZeneca AB (SE) 2007-02-28 EP claimed
WO-2005115972-A1 THERAPEUTIC COMPOUNDS ASTRAZENECA AB (SE) 2005-12-08 WO claimed
EP-1756044-A1 THERAPEUTIC COMPOUNDS AstraZeneca AB (SE) 2007-02-28 EP disclosed
WO-2005115972-A1 THERAPEUTIC COMPOUNDS ASTRAZENECA AB (SE) 2005-12-08 WO disclosed